The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Results after long-term follow-up from the CAN2007 phase I/II study of weekly or twice-weekly bortezomib in patients (pts) with relapsed systemic light-chain (AL) amyloidosis.
Donna Ellen Reece
Honoraria - Bristol-Myers Squibb; Celgene; Janssen; Merck; Novartis; Otsuka
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Millennium; Novartis; Otsuka
Ute Hegenbart
Honoraria - Janssen
Vaishali Sanchorawala
Research Funding - Celgene; Millennium; Onyx
Giampaolo Merlini
Consultant or Advisory Role - Elan; Pfizer
Giovanni Palladini
No relevant relationships to disclose
Joan Blade
Consultant or Advisory Role - Celgene; Janssen
Honoraria - Celgene; Janssen
Jean-Paul Fermand
No relevant relationships to disclose
Hani Hassoun
Research Funding - Millennium
Leonard Heffner
Honoraria - Millennium
Research Funding - Millennium
Other Remuneration - Millennium
Lixia Pei
Employment or Leadership Position - Janssen Research & Development
Christopher Enny
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Dixie Esseltine
Employment or Leadership Position - Millennium
Stock Ownership - Takeda
Helgi Van De Velde
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Andrew Cakana
Employment or Leadership Position - Janssen Research & Development
Stock Ownership - Johnson & Johnson
Raymond Comenzo
Consultant or Advisory Role - Millennium
Research Funding - Millennium